Trade

with

BioDelivery Sciences International Inc
(NASDAQ: BDSI)
AdChoices
16.62
+0.24
+1.47%
After Hours :
16.62
0.00
0.00%

Open

16.59

Previous Close

16.38

Volume (Avg)

433.05k (1.10M)

Day's Range

16.30-16.62

52Wk Range

4.16-18.48

Market Cap.

819.36M

Dividend Rate ( Yield )

-

Beta

2.42

Shares Outstanding

49.30M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 11.36M

    • Net Income

    • -57.39M

    • Market Cap.

    • 819.36M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -102.47

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.42

    • Forward P/E

    • 208.33

    • Price/Sales

    • 16.89

    • Price/Book Value

    • 13.26

    • Price/Cash flow

    • -16.03

      • EBITDA

      • -55.05M

      • Return on Capital %

      • -55.61

      • Return on Equity %

      • -95.80

      • Return on Assets %

      • -55.61

      • Book Value/Share

      • 1.25

      • Shares Outstanding

      • 49.30M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 20.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • 0.30

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 402.30

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 112.32

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 94.15

            • 82.75

            • Pre-Tax Margin

            • -102.68

            • 39.38

            • Net Profit Margin

            • -102.47

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 79.30

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -309.30

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -309.50

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.13

              • 0.76

              • Current Ratio

              • 3.20

              • 2.92

              • Quick Ratio

              • 3.15

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.68

              • 2.21

              • Book Value/Share

              • 1.25

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -16.21

                • 217.39

                • P/E Ratio 5-Year High

                • -18.32

                • 634.30

                • P/E Ratio 5-Year Low

                • -0.76

                • 124.82

                • Price/Sales Ratio

                • 16.61

                • 9.52

                • Price/Book Value

                • 13.04

                • 8.61

                • Price/Cash Flow Ratio

                • -16.03

                • 50.51

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -95.80

                        (-)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -55.61

                        (-18.00)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -71.21

                        (-)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • 3.05

                      • 1.48

                      • Asset Turnover

                      • 0.54

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -56.40M
                      Operating Margin
                      -496.68
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -16.03
                      Ownership

                      Institutional Ownership

                      71.60%

                      Top 10 Institutions

                      44.16%

                      Mutual Fund Ownership

                      41.35%

                      Float

                      79.83%

                      5% / Insider Ownership

                      9.25%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Federated Kaufmann Fund

                      •  

                        3,250,000

                      • -9.09

                      • 6.62

                      • PowerShares Dynamic Pharmaceuticals Port

                      •  

                        2,562,441

                      • 0.00

                      • 4.98

                      • Fidelity® Ser Opportunistic Insights Fd

                      •  

                        1,847,366

                      • 0.00

                      • 3.75

                      • SPDR® S&P Pharmaceuticals ETF

                      •  

                        1,411,527

                      • 0.00

                      • 2.74

                      • Oak Ridge Small Cap Growth Fund

                      •  

                        1,370,000

                      • 48.11

                      • 2.78

                      • AST Federated Aggressive Growth

                      •  

                        930,800

                      • 0.00

                      • 1.89

                      • Federated Kaufmann Small Cap Fund

                      •  

                        849,800

                      • -8.62

                      • 1.73

                      • Vanguard Total Stock Mkt Idx

                      •  

                        672,344

                      • 1.51

                      • 1.36

                      • iShares Russell 2000 (AU)

                      •  

                        625,851

                      • -1.46

                      • 1.22

                      • Vanguard US Discoveries Fund

                      •  

                        524,850

                      • -2.34

                      • 1.07

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Federated Global Inv Mgmt Corp

                      •  

                        5,119,200

                      • +410.39%

                      • 10.42

                      • Broadfin Capital, LLC

                      •  

                        3,372,054

                      • -2.88%

                      • 6.87

                      • Fidelity Management and Research Company

                      •  

                        2,682,983

                      • -11.91%

                      • 5.46

                      • HOPKINS CAPITAL GROUP II LLC

                      •  

                        2,375,490

                      • -27.48%

                      • 4.90

                      • Adage Capital Partners Gp LLC

                      •  

                        2,250,000

                      • -18.18%

                      • 4.58

                      • Deerfield Management Co

                      •  

                        1,328,300

                      • -66.68%

                      • 2.70

                      • BlackRock Fund Advisors

                      •  

                        1,260,646

                      • -1.63%

                      • 2.57

                      • Vanguard Group, Inc.

                      •  

                        1,178,920

                      • +10.08%

                      • 2.40

                      • Foresite Capital Management I, LLC

                      •  

                        700,000

                      • 0.00%

                      • 1.43

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Speculative Growth

                      Style

                      Small Growth

                      BioDelivery Sciences International Inc was incorporated in the State of Indiana on January 6, 1997 and reincorporated as a Delaware corporation in 2002. The Company, along with its subsidiaries, is a specialty pharmaceutical company ...morethat is developing and commercializing, either on its own or in partnerships with third parties, new applications of proven therapeutics to address important unmet medical needs using both proven and new drug delivery technologies. It has developed and is continuing to develop pharmaceutical products targeted mainly in the areas of pain management and addiction. In formulating its products and product candidates, it utilizes the novel, patent protected and proprietary BioErodible MucoAdhesive drug delivery technology, a small, erodible polymer film for application to the...more buccal mucosa, the lining inside the cheek. Its first U.S. Food and Drug Administration approved product, ONSOLIS, as well as its pipeline of product candidates; utilize its BEMA technology. On July 16, 2009, the Company announced the U.S. approval of its first product, ONSOLIS. It is indicated for the treatment of breakthrough pain in opioid tolerant patients with cancer. Its next product, currently in development, is BEMA Buprenorphine, a potential treatment for moderate to severe chronic pain. Its BioErodible MucoAdhesive drug delivery technology consists of a small, erodible polymer film for application to the buccal mucosa. BEMA films have the capability to deliver a rapid, reliable dose of drug across the buccal mucosa for time-critical conditions such as breakthrough cancer pain or in situations where gastrointestinal absorption of an oral drug is not practical or reliable. Its competitors include: LTS Lohmann Therapie-Systeme AG, ARx LLC and MonoSol Rx LLC. The Company is subject to regulation for safety, efficacy and quality by governmental authorities in the United States and other countries.lessless

                      Key People

                      Dr. Mark A. Sirgo,Pharm.D.

                      CEO/Director/President

                      Dr. Francis E. O'Donnell,Jr,M.D.

                      Chairman of the Board/Director

                      Ernest Robert De Paolantonio

                      CFO/Chief Accounting Officer/Secretary

                      Andrew L. Finn,Pharm.D.

                      Executive VP, Divisional

                      Albert J. Medwar

                      Vice President, Divisional

                      • BioDelivery Sciences International Inc

                      • 801 Corporate Center Drive

                      • Raleigh, NC 27607

                      • USA.Map

                      • Phone: +1 919 582-9050

                      • Fax: +1 919 582-9051

                      • bdsi.com

                      Incorporated

                      1997

                      Employees

                      24

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: